Response Genetics Inc (RGDXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 1640 MARENGO ST.,
LOS ANGELES,, CA 90033
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2015
MRQ
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,2228,1499,041
Cash and cash equivalents 2,2228,1499,041
Receivables 7,8106,2265,373
Prepaid expense and other current assets576
Other undisclosed current assets 1,183982 
Total current assets: 11,21615,35614,991
Noncurrent Assets
Property, plant and equipment 1,4061,9351,023
Intangible assets, net (including goodwill) 631767575
Intangible assets, net (excluding goodwill) 631767575
Other noncurrent assets 192 
Total noncurrent assets: 2,2292,7021,599
TOTAL ASSETS: 13,44518,05816,589
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,9794,2122,917
Interest and dividends payable 150  
Employee-related liabilities 1,5481,8511,382
Accounts payable 1,6101,6941,191
Accrued liabilities 672667344
Debt 1011571,159
Deferred revenue and credits   483
Other undisclosed current liabilities 9681,294713
Total current liabilities: 5,0485,6635,272
Noncurrent Liabilities
Long-term debt and lease obligation 9,5671,13684
Long-term debt, excluding current maturities 9,4641,000 
Capital lease obligations 10313684
Total noncurrent liabilities: 9,5671,13684
Total liabilities: 14,6156,7995,356
Temporary equity, carrying amount  5,50011,776
Equity
Equity, attributable to parent, including: (1,170)5,759(542)
Common stock 388337232
Additional paid in capital 77,69870,98656,766
Accumulated other comprehensive loss (260)(267)(264)
Accumulated deficit (78,997)(65,297)(57,277)
Warrants and rights outstanding 681  
Other undisclosed equity, attributable to parent (681)  
Total equity: (1,170)5,759(542)
TOTAL LIABILITIES AND EQUITY: 13,44518,05816,589

Income Statement (P&L) ($ in thousands)

3/31/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 16,72019,80118,737
Cost of revenue (438)(10,456)(10,416)
Cost of goods and services sold (10,011)(10,456) 
Other undisclosed gross profit (9,574)  
Gross profit: 6,7099,3458,321
Operating expenses (19,716)(17,291)(17,800)
Other undisclosed operating income   1,822
Operating loss: (13,008)(7,946)(7,657)
Nonoperating income (expense) (27)17(14)
Other nonoperating expense   (14)
Interest and debt expense (665)(92)(86)
Loss from continuing operations before equity method investments, income taxes: (13,699)(8,021)(7,757)
Other undisclosed income from continuing operations before income taxes  0 
Loss from continuing operations: (13,699)(8,021)(7,757)
Loss before gain (loss) on sale of properties: (13,699)(8,021)(7,757)
Net loss available to common stockholders, diluted: (13,699)(8,021)(7,757)

Comprehensive Income ($ in thousands)

3/31/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Net loss: (13,699)(8,021)(7,757)
Comprehensive loss: (13,699)(8,021)(7,757)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 7(3)3
Comprehensive loss, net of tax, attributable to parent: (13,692)(8,024)(7,754)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: